myotubes

  1. D

    Glp1 future enhancing drug blocks mstn gene myostatin

    Skeletal muscle atrophy is defined as a reduction of muscle mass caused by excessive protein degradation. However, the development of therapeutic interventions is still in an early stage. Although glucagon‐like peptide‐1 receptor (GLP‐1R) agonists, such as exendin‐4 (Ex‐4) and dulaglutide, are...
    • darrenW29
    • Thread
    • addition agonist atrophic atrophy dulaglutide effect enhancing expression ex‐4 factors function glp‐1r increased injection kinase mass model mstn muscle myostatin myotubes protein signalling therapeutic treatment
    • Replies: 0
    • Forum: General Conversation Forum
Back
Top